Abruzzese, Elisabetta
ASL Roma · St. Eugenio Hospital
5 papers on CoChatORCID 0000-0001-5228-6491
Most cited papers
- Verified
Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
Apperley, J. F., Cortes, J. E., Kim, D.-W., Roy, L., Roboz, G. J., Rosti, G., Bullorsky, E. O., Abruzzese, E., Hochhaus, A., Heim, D., et al. (2009) · Journal of Clinical Oncology
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 194
- Verified
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
Soverini, S., Bavaro, L., De Benedittis, C., Martelli, M., Iurlo, A., Orofino, N., Sica, S., Sorà, F., Lunghi, F., Ciceri, F., et al. (2020) · Blood
Chronic Myeloid Leukemia TreatmentsLung Cancer Treatments and Mutations
Cited by 100
- Verified
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network
Specchia, G., Pregno, P., Breccia, M., Castagnetti, F., Monagheddu, C., Bonifacio, M., Tiribelli, M., Stagno, F., Caocci, G., Martino, B., et al. (2021) · Frontiers in Oncology
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 21
- Verified
The Impact of Ponatinib on Pregnancy Outcomes
Abruzzese, E., Chelysheva, E., Bardey-Kanaan, M., Soichez, R., Nguyen, N. T., Kelly, D., Rizzo, F., Patos, P., & Apperley, J. (2024) · Blood
Chronic Myeloid Leukemia TreatmentsPregnancy and Medication Impact
Cited by 8
- Verified
Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
Chelysheva, E., Apperley, J., Turkina, A., Yassin, M. A., Rea, D., Nicolini, F. E., Barraco, D., Kazakbaeva, K., Saliev, S., Abulafia, A. S., et al. (2024) · Leukemia
Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free